In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Q4 earnings for companies such as Johnson & Johnson, Teva, and Roche highlight the impact of significant innovations brought ...

Nubeqa was approved for a similar indication in the US last July, and will compete in the nmCRPC market with Janssen's Erleada (apalutamide) and Astellas/Pfizer's Xtandi (enzalutamide).

Patients over the age of 50 have an increased risk of mortality following hip fracture, which is dependent on factors such as health and post-fracture comorbidities. Findings from a meta-analysis ...

This study aimed to investigate the nature of life impacts following ankle fractures with the intention of describing a thematic conceptual framework based on these lived experiences of people who ...